Senores Pharmaceuticals Limited — Updates, 20-05-2025: Press Release

Senores Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year. Its US subsidiary acquired USFDA-approved ANDA for Enalapril Maleate Tablets (2.5mg to 20mg) from Wockhardt, targeting the USD 28.6–109.2 Mn US hypertension and heart failure market. Funded by IPO proceeds, this acquisition strengthens Senores’ US generics portfolio and supports growth in regulated markets.